Amy Goodrich

Research Associate

20002017

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2017
2009

Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma

Kasamon, Y. L., Jones, R. J., Brodsky, R. A., Fuchs, E. J., Matsui, W., Luznik, L., Powell, J. D., Blackford, A. L., Goodrich, A., Gocke, C. D., Abrams, R. A., Ambinder, R. F. & Flinn, I. W., Oct 30 2009, In : Annals of Oncology. 21, 6, p. 1203-1210 8 p.

Research output: Contribution to journalArticle

2008

Bendamustine: A novel cytotoxic agent for hematologic malignancies

Blumel, S., Goodrich, A., Martin, C. & Dang, N. H., Oct 1 2008, In : Clinical journal of oncology nursing. 12, 5, p. 799-806 8 p.

Research output: Contribution to journalArticle

2007

Constitutional duplication of a region of chromosome Yp encoding AMELY, PRKY, and TBL1Y: Implications for sex chromosome analysis and bone marrow engraftment analysis

Murphy, K. M., Cohen, J. S., Goodrich, A., Long, P. P. & Griffin, C. A., Jul 2007, In : Journal of Molecular Diagnostics. 9, 3, p. 408-413 6 p.

Research output: Contribution to journalArticle

2006

A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma

Waselenko, J. K., Reese, A., Park, K., Lucas, M., Goodrich, A., Willis, C. R., Diehl, L. F., Grever, M. R., Byrd, J. C. & Flinn, I. W., May 1 2006, In : Annals of hematology. 85, 5, p. 301-307 7 p.

Research output: Contribution to journalArticle

2001

Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity

Byrd, J. C., Murphy, T., Howard, R. S., Lucas, M. S., Goodrich, A., Park, K., Pearson, M., Waselenko, J. K., Ling, G., Grever, M. R., Grillo-Lopez, A. J., Rosenberg, J., Kunkel, L. & Flinn, I. W., Apr 15 2001, In : Journal of Clinical Oncology. 19, 8, p. 2153-2164 12 p.

Research output: Contribution to journalArticle

2000

A prospective study to evaluate the nursing management of initial rituximab infusions in outpatient settings

Goodrich, A. L., Flinn, L. W. & Morrison, C., Dec 1 2000, In : Blood. 96, 11 PART II, p. 237b

Research output: Contribution to journalArticle

Cell surface complement inhibitors cd55 and cd59 may mediate chronic lymphocytic leukemia (cll) resistance to rituximab therapy

Banner, R., Pearson, M., Flinn, W., Shinn, C. A., Goodrich, A., Lucas, M. & Byrd, J. C., Dec 1 2000, In : Blood. 96, 11 PART I, p. 164a

Research output: Contribution to journalArticle

Immunotherapy with Rituximab during Peripheral Blood Stem Cell Transplantation for Non-Hodgkin's Lymphoma

Flinn, I. W., O'Donnell, P. V., Goodrich, A., Vogelsang, G., Abrams, R., Noga, S., Marcellus, D., Borowitz, M., Jones, R. & Ambinder, R. F., Jan 1 2000, In : Biology of Blood and Marrow Transplantation. 6, 6, p. 628-632 5 p.

Research output: Contribution to journalArticle

Open Access

Theophylline, pentostatin (Nipent), and chlorambucil: A dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders

Byrd, J. C., Grever, M. R., Waselenko, J. K., Willis, C. R., Park, K., Goodrich, A., Lucas, M. A., Shinn, C. & Flinn, I. W., Jul 12 2000, In : Seminars in oncology. 27, 3 SUPPL. 5, p. 37-40 4 p.

Research output: Contribution to journalArticle